- Onychoschizia, commonly known as nail splitting or brittle nails, is a frequently reported nail disorder affecting a significant portion of the global population, particularly women. The rising awareness of nail health, increasing prevalence of nutritional deficiencies, and growing consumer demand for aesthetic appearance are driving the demand for effective treatment options
- The escalating demand for onychoschizia treatments is primarily fueled by the increasing availability of over-the-counter solutions, growth in dermatological consultations, and the integration of nail health products in the cosmetic and pharmaceutical sectors
- North America dominated the onychoschizia treatment market with the largest revenue share of 40.9% in 2024, owing to heightened awareness of nail health, high healthcare expenditure, and access to advanced dermatological care. The U.S. leads the region with strong sales of topical creams, dietary supplements, and prescription treatments tailored to brittle nail conditions
- Asia-Pacific is expected to be the fastest-growing region in the onychoschizia treatment market during the forecast period, supported by increasing urbanization, rising disposable incomes, and growing adoption of personal care and grooming products across emerging economies such as China, India, and South Korea
- The biotin segment dominated the onychoschizia treatment market with a market share of 54.3% in 2024, driven by its clinically validated role in enhancing nail strength and reducing brittleness. Its wide over-the-counter availability and endorsement by healthcare professionals have further fueled consumer trust and adoption, particularly among individuals seeking long-term dietary support for nail health
